May 30, 2018
JAMA. Published online May 30, 2018. doi:10.1001/jama.2018.5420
Medical organizations are at odds over new guidance that recommends easing hemoglobin A1C (HbA1c) targets for patients with type 2 diabetes. The updated guidance statement from the American College of Physicians (ACP), which focuses on glycemic control with medications, says clinicians should personalize goals and aim to achieve an HbA1c level of between 7% and 8% for most patients with type 2 diabetes.
Experts agree that the best HbA1c target for a patient with diabetes is a personalized one.